Select Medical Holdings Corporation vs TG Therapeutics Inc — how do they compare? Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: TG Therapeutics Inc is far larger — about 4× Select Medical Holdings Corporation's market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SEM | TGTX | |
|---|---|---|
Market Cap | $2.05B | $8.26B |
Sector | Health | Health |
52-Week High | $16.66 | $59.06 |
52-Week Low | $11.77 | $26.39 |
Enterprise Value | $5.01B | $8.50B |
Dividend Yield | 1.51% | — |
Trailing returns across standard periods
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →